The authors used ex vivo retroviral gene transfer to constitutively overexpress VEGF in myoblasts, which were subsequently transplanted in the myocardial wall of mice. Unregulated VEGF expression ...

AKESO (09926.HK) announced the global first-in-class PD-1/VEGF bi-specific antibody, ivonescimab, has received approval from the National Medical Products Administration (NMPA) for its supplementary ...

AKESO (09926.HK) sank to a bottom of $84.1. It last traded at $84.1, down 14.96%, on a volume of 1.254 million shares and a ...

Akeso (AKESF) announced that its “globally first-in-class PD-1/VEGF bispecific antibody,” ivonescimab, has received approval from the National ...

The quest for VEGF and other factors that promote tumour ... ultimately leading to the gene. As so frequently happens in science, independent and apparently unrelated lines of research converged.

In a porcine model, lymphatic vessel regeneration improved following adenoviral gene transfer of VEGF-C with gene therapy. In a subsequent phase I clinical study, the VEGF-C therapy proved to be ...

Vascular biology research forms a major part of the Bristol Renal interest and expertise from the study of glomerular endothelial cells in vitro and in vivo to the role of glycocalyx or the importance ...

In honor of Ophthalmology Times’ 50th anniversary, we asked a panel of leading ophthalmologists and optometrists across subspecialties to reflect on the most transformative innovations in the field ...

ARVO meeting will be held in Salt Lake City, Utah and feature presentation on clinical trials from around the globe.

Tumstatin serves as an anti-inflammatory and anti-vascular endothelial growth factor (VEGF ... its modifier gene therapy candidate. OCU410 is a modifier gene therapy candidate designed for ...

Key signaling pathways (VEGF, ANGPT, EPHA ... Cross-species comparisons of spatial gene expression could reveal conserved or species-specific mechanisms, offering novel targets for conditions ...